NYSE:CNMDMedical Equipment
CONMED (CNMD) Is Up 5.6% After Q4 Beat But Cut Full-Year Outlook - What's Changed
In its latest reported quarter, CONMED posted 7.9% year-on-year revenue growth that exceeded analyst expectations, but its full-year revenue and EPS fell short of prior guidance, highlighting operational and forecasting challenges in a complex medtech environment.
This mix of a solid quarterly performance and weaker full-year guidance underscores the tension between near-term execution and investor concerns about the company’s longer-term growth trajectory.
Next, we’ll examine how strong...